SHG:688068 - Beijing Hotgen Biotech Co Ltd

Beijing Hotgen Biotech Co Ltd
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2016 Q4	2017 Q4	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	38.03% -2.1%	40.71% 7.1%	39.78% -2.3%	40.57% 2.0%	39.52% -2.6%	26.56% -32.8%	16.6% -37.5%	11.81% -28.9%	-10.73% -	5.06% -	-5.82% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	61.39% -2.7%	59.54% -3.0%	58.86% -1.1%	54.56% -7.3%	55.56% 1.8%	53.71% -3.3%	49.92% -7.1%	52.2% 4.6%	51.3% -1.7%	56.95% 11.0%	51.72% -9.2%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	50.13% -4.5%	49.76% -0.7%	48.63% -2.3%	42.06% -13.5%	42.25% 0.5%	34.84% -17.5%	23.97% -31.2%	21.22% -11.5%	3.69% -82.6%	-0.57% -	-14.19% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	4.16B 3.5%	5.37B 29.0%	5.51B 2.5%	3.82B -30.7%	4.58B 20.1%	3.56B -22.4%	2.4B -32.7%	1.82B -24.1%	954.29M -47.5%	541.25M -43.3%	454.44M -16.0%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.4B -6.9%	3.64B 51.8%	3.92B 7.6%	3.86B -1.7%	3.93B 1.9%	3.9B -0.7%	3.7B -5.0%	3.7B -0.1%	3.6B -2.6%	3.56B -1.2%	3.49B -2.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	247.59M -45.1%	771.01M 211.4%	431.68M -44.0%	458.29M 6.2%	348.12M -24.0%	545.59M 56.7%	300.51M -44.9%	270.61M -9.9%	200.64M -25.9%	202.56M 1.0%	205.34M 1.4%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.14B 1.1%	2.84B 32.9%	3.45B 21.3%	3.35B -2.9%	3.54B 5.6%	3.34B -5.8%	3.39B 1.6%	3.43B 1.2%	3.4B -0.8%	3.36B -1.2%	3.28B -2.5%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	2.64B -	-	1.52B -	-	978.75M -	-	325.21M -	-	-51.95M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	40.97M -27.9%	382.61M 833.9%	825.52M 115.8%	484.16M -41.4%	316.75M -34.6%	1.15B 264.4%	644.71M -44.1%	664.37M 3.1%	596.78M -10.2%	523.21M -12.3%	318.98M -39.0%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	313.47M -35.9%	1.15B 268.2%	660.12M -42.8%	674.63M 2.2%	609.2M -9.7%	523.21M -14.1%	314.53M -39.9%	319.03M 1.4%	189.87M -40.5%	272.39M 43.5%	233.86M -14.1%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.24B -15.8%	2.25B 81.4%	1.24B -44.9%	1.05B -15.1%	1.5B 42.4%	413.54M -72.3%	66.84M -83.8%	-294.65M -	-550.05M -	-465.31M -	-150.05M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	2.2B -	-	1.57B -	-	925.12M -	-	173.35M -	-	15.05M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.203 1.3%	23.743 38.0%	23.791 0.2%	16.813 -29.3%	19.673 17.0%	10.28 -47.7%	4.36 -57.6%	2.38 -45.4%	-1.08 -	0.31 -	-0.29 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	114.28% 0.4%	121.9% 6.7%	91.37% -25.0%	56.62% -38.0%	63.77% 12.6%	30.58% -52.0%	11.63% -62.0%	6.33% -45.5%	-2.95% -	0.82% -	-0.79% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	102.58% 7.9%	96.13% -6.3%	69.94% -27.3%	48.1% -31.2%	57.22% 19.0%	25.05% -56.2%	10.43% -58.4%	5.68% -45.5%	-2.72% -	0.73% -	-0.74% -